Login to Your Account



Meddlesome kidneys

EPO induces antiangiogenic drug resistance

By John Fox
Staff Writer

Friday, October 27, 2017

Kidney-produced erythropoietin (EPO) desensitizes tumors to the effects of antiangiogenic drugs, improving the understanding of the mechanisms underlying resistance to these agents and potentially, how to improve their therapeutic efficacy.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription